Cargando…

Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT

PURPOSE: It is often difficult to differentiate parkinsonism, especially when patients show uncertain parkinsonian features. We investigated the usefulness of dopamine transporter (DAT) imaging for the differential diagnosis of inconclusive parkinsonism using [(18)F]FP-CIT PET. METHODS: Twenty-four...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Eunkyung, Hwang, Yu Mi, Lee, Chan-Nyoung, Kim, Sujin, Oh, Sun Young, Kim, Young Chul, Choe, Jae Gol, Park, Kun Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028478/ https://www.ncbi.nlm.nih.gov/pubmed/24900150 http://dx.doi.org/10.1007/s13139-013-0253-1

Ejemplares similares

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Comparison of perfusion (18)F-FP-CIT PET and (99m)Tc-ECD SPECT in parkinsonian disorders
por: Chun, KyungAh, et al.
Publicado: (2021)

Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of (18)F-FP-CIT PET/CT
por: Cheon, Miju, et al.
Publicado: (2022)

F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment
por: Jeong, Young Jin, et al.
Publicado: (2017)

Salivary Gland Uptake on (18)F-FP-CIT PET as a New Biomarker in Patients With Parkinsonism
por: Kang, Seo Young, et al.
Publicado: (2023)

Differential diagnosis of patients with atypical Parkinsonian syndrome using (18)F-FDG and (18)F-FP CIT PET: A report of five cases
por: Yoo, Jang, et al.
Publicado: (2022)

Early-phase (18)F-FP-CIT and (18)F-flutemetamol PET were significantly correlated
por: An, Young-Sil, et al.
Publicado: (2021)

Heterogeneity by global and textural feature analysis in F-18 FP-CIT brain PET images for diagnosis of Parkinson's disease
por: Yoon, Hyun Jin, et al.
Publicado: (2021)

Diagnostic accuracy of dual-phase (18)F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism
por: Oh, Minyoung, et al.
Publicado: (2021)

18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom
por: Tang, Songhan, et al.
Publicado: (2022)

Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022)

A Case of Genetically Confirmed Chorea-Acanthocytosis: Brain [(18)F]FDG-PET and [(18)F]FP-CIT-PET Findings
por: Lee, Jong-Mok, et al.
Publicado: (2020)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Correlation Between Neuromelanin-Sensitive MRI and (18)F-FP-CIT PET in Early-Stage Parkinson’s Disease: Utility of a Voxel-Wise Analysis by Using High-Spatial-Resolution MRI
por: Park, Seongbeom, et al.
Publicado: (2023)

Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients
por: Hida, Kosuke, et al.
Publicado: (2016)

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
por: Yang, YoungSoon, et al.
Publicado: (2017)

Dual phase (18)F-FP CIT PET and (99m)Tc- ECD SPECT findings of Huntington's disease()
por: Chun, KyungAh
Publicado: (2022)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Usefulness of F-18 FP-CIT PET to predict dopamine-responsive hand tremor in patients other than Parkinson's disease: Two case reports
por: Yu, Kwang Jae, et al.
Publicado: (2018)

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [(123)I]FP-CIT SPECT/CT Brain Imaging
por: Vu, Jeanne P., et al.
Publicado: (2021)

Intrasubject relationship between striatal (18)F-FP-CIT uptake and cardiac (123)I-MIBG uptake differs by motor subtype in early Parkinson disease
por: Jang, Wooyoung, et al.
Publicado: (2021)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
por: Walker, Zuzana, et al.
Publicado: (2016)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
por: Park, So Hyeon, et al.
Publicado: (2019)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma
por: Lee, Sinae, et al.
Publicado: (2013)

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?
por: Bittner, Verena, et al.
Publicado: (2011)

Computer-aided diagnosis for ((123)I)FP-CIT imaging: impact on clinical reporting
por: Taylor, Jonathan Christopher, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat
por: Nikolaus, Susanne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hamuecaa8ruh468jtlj44v8b8q